Web6 apr. 2024 · JNJ has a market cap or net worth of $515.24 billion as of April 9, 2024. Its market cap has increased by 9.11% in one year. Market Cap 515.24B Enterprise Value 531.38B 1-Year Change 9.11% Ranking # 11 Category Mega-Cap Stock Price $ 165.15 Market Cap Chart No chart data available WebJohnson & Johnson annual free cash flow for 2024 was $20.469B, a 0.12% decline from 2024. Johnson & Johnson annual free cash flow for 2024 was $20.494B, a 11.6% decline from 2024. Compare JNJ With Other Stocks From: To: Zoom: 10,000 12,000 14,000 16,000 18,000 20,000 22,000 24,000 Annual Values
JNJ Johnson & Johnson Annual Income Statement - WSJ
Web13 apr. 2024 · Johnson & Johnson has generated $6.74 earnings per share over the last year ($6.74 diluted earnings per share) and currently has a price-to-earnings ratio of 24.5. Earnings for Johnson & Johnson are expected to grow by 4.10% in the coming year, from $10.50 to $10.93 per share. WebCompare the dividends per share compound annual growth rate (cagr) of iShares U.S. Medical Devices ETF IHI and Johnson & Johnson JNJ. Get comparison charts for tons of financial metrics! is gene a segment of dna
Johnson & Johnson Reports Q4 and Full-Year 2024 Results
Web12 apr. 2024 · Industry Drug Manufacturers - General Investment Style Large Value Day Range 164.80 – 167.23 Year Range 150.11 – 186.69 Market Cap 515.2420 Bil Volume / Avg 9.6 Mil / 8.7 Mil Price / Sales 4.63... Web6 apr. 2024 · Find the latest historical data for Johnson & Johnson Common Stock (JNJ) at Nasdaq.com. Johnson & Johnson Common Stock (JNJ) Historical Data Nasdaq Skip to … WebJNJ chart Today 2.07% Week 3.06% 1 month 10.94% 6 months −14.35% Year to date 10.94% 1 year 12.11% 5 years −21.89% All time −99.99% Key stats Market … is gene and chromosome the same